Matthew Feinstein, a Third Coast CFAR Pilot Awardee, will speak at the “HIV and CVD: Reducing Cardiovascular Risk in Patients with HIV/AIDS” event on March 17. With Priscilla Hsue, MD, FACC, they will address the specific need of cardiovascular practitioners, family practice physicians and infectious disease specialists to understand the importance of the intersection between cardiovascular disease (CVD) and HIV infection, the impact of antiretroviral therapy (ART) on cardiovascular (CV) risk, and the ability to implement recommended risk-reduction approaches to reduce the patients’ risk of CVD.
- NIH Releases Three Ending the HIV Epidemic RFAs
- NIMHD Announces Release of NIH-Wide Minority Health and Health Disparities Strategic Plan 2021-2025
- CFAR Faculty Members Announce New Research Center Dedicated to Helping Sexual and Gender Minority Youth Thrive
- Q&A with Jenny Trinitapoli, the New Director of the CFAR Developmental Core
- Endowed Professorship Opportunity at University of Alabama at Birmingham (UAB)
- Join the new Inter-CFAR Substance Use Research Community (I-SURC)